EE03392B1 - Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks - Google Patents

Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks

Info

Publication number
EE03392B1
EE03392B1 EE9700094A EE9700094A EE03392B1 EE 03392 B1 EE03392 B1 EE 03392B1 EE 9700094 A EE9700094 A EE 9700094A EE 9700094 A EE9700094 A EE 9700094A EE 03392 B1 EE03392 B1 EE 03392B1
Authority
EE
Estonia
Prior art keywords
treatment
dependent diabetes
insulin dependent
diabetes mellitus
aminoguanidine
Prior art date
Application number
EE9700094A
Other languages
English (en)
Other versions
EE9700094A (et
Inventor
A. Vaillancourt Valerie
D. May Paul
P. Tanis Steven
A. Tucker John
D. Meglasson Martin
J. Schostarez Heinrich
D. Larsen Scott
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of EE9700094A publication Critical patent/EE9700094A/et
Publication of EE03392B1 publication Critical patent/EE03392B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700094A 1994-11-23 1995-11-13 Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks EE03392B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
EE9700094A EE9700094A (et) 1997-10-15
EE03392B1 true EE03392B1 (et) 2001-04-16

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700094A EE03392B1 (et) 1994-11-23 1995-11-13 Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks

Country Status (24)

Country Link
US (2) US6166080A (et)
EP (1) EP0793646B1 (et)
JP (1) JPH10509455A (et)
CN (2) CN1097580C (et)
AT (1) ATE205188T1 (et)
AU (1) AU705893B2 (et)
BR (1) BR9509741A (et)
CA (1) CA2202265A1 (et)
CZ (1) CZ288597B6 (et)
DE (2) DE793646T1 (et)
DK (1) DK0793646T3 (et)
EE (1) EE03392B1 (et)
ES (1) ES2163531T3 (et)
FI (1) FI972185A0 (et)
GE (1) GEP20002026B (et)
HU (1) HUT77133A (et)
MX (1) MX9703807A (et)
NO (1) NO308992B1 (et)
NZ (1) NZ297604A (et)
PL (1) PL184614B1 (et)
PT (1) PT793646E (et)
RU (1) RU2162462C2 (et)
SK (1) SK282357B6 (et)
WO (1) WO1996016031A1 (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
AU3117497A (en) 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
AU1725197A (en) * 1997-02-13 1998-09-08 Smithkline Beecham Plc Use of nitric oxid synthase inhibitors for the treatment of diabetes
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
WO2009133152A1 (en) * 2008-04-29 2009-11-05 Becton, Dickinson And Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
AU2008357111B2 (en) * 2008-06-26 2013-05-09 Laboratorios Silanes, S.A. De C.V. A new metformin Glycinate salt for blood glucose control
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
EP3196271B1 (en) * 2015-04-23 2019-01-09 Mitsubishi Gas Chemical Company, Inc. Gas-generating agent, and process for producing foamed object using same
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
EP4072561A4 (en) 2019-12-11 2023-11-29 Inspirna, Inc. CANCER TREATMENT METHODS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
CZ136997A3 (cs) 1998-02-18
CA2202265A1 (en) 1996-05-30
PL184614B1 (pl) 2002-11-29
BR9509741A (pt) 1997-10-21
DK0793646T3 (da) 2001-12-17
ATE205188T1 (de) 2001-09-15
AU705893B2 (en) 1999-06-03
FI972185A7 (fi) 1997-05-22
EP0793646A1 (en) 1997-09-10
CN1164226A (zh) 1997-11-05
CN1097580C (zh) 2003-01-01
JPH10509455A (ja) 1998-09-14
WO1996016031A1 (en) 1996-05-30
AU4279696A (en) 1996-06-17
GEP20002026B (en) 2000-04-10
NO308992B1 (no) 2000-11-27
CN1377642A (zh) 2002-11-06
SK64097A3 (en) 1997-11-05
CZ288597B6 (cs) 2001-07-11
DE793646T1 (de) 1999-12-30
US6166080A (en) 2000-12-26
DE69522580D1 (de) 2001-10-11
NZ297604A (en) 2000-07-28
HUT77133A (hu) 1998-03-02
DE69522580T2 (de) 2002-10-10
FI972185L (fi) 1997-05-22
ES2163531T3 (es) 2002-02-01
MX9703807A (es) 1997-08-30
NO972346L (no) 1997-07-23
EP0793646B1 (en) 2001-09-05
PT793646E (pt) 2002-03-28
US6329545B1 (en) 2001-12-11
RU2162462C2 (ru) 2001-01-27
PL320361A1 (en) 1997-09-29
SK282357B6 (sk) 2002-01-07
NO972346D0 (no) 1997-05-22
FI972185A0 (fi) 1997-05-22
EE9700094A (et) 1997-10-15

Similar Documents

Publication Publication Date Title
EE03392B1 (et) Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
SE9502921D0 (sv) New compounds
NO961356D0 (no) Antracyklinonderivater, samt anvendelse derav ved amyloidose
ZA891408B (en) Substituted 1,2,4-triazinediones,processes for their preparation and their use
NO943100L (no) Forbindelser for anvendelse i kontrastmidler for radiografi
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
AU648285B2 (en) Coating material, process for producing it and its use
FI955829A0 (fi) Heterosyklinen kemia
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
IL158356A0 (en) Benzoheterocycles
EP0566666A4 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
ES2074250T3 (es) Azocolorantes, procedimiento para su preparacion y su empleo.
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ZA200103910B (en) 1,4-Diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds.
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ
IT216599Z2 (it) Attrezzo manuale, per lo svolgimento ed il tensionamento di film flessibele da bobina.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

MM4A Lapsed by not paying the annual fees

Effective date: 20031113